Crimson Life Sciences Release: Expert Opinion Webcast Reveals $400 Million Potential Savings for Medical Device Industry
2/14/2012 8:02:37 AM
BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Crimson Life Sciences, a division of TransPerfect and the world’s only ISO 13485 and ISO 14971 certified translation provider, announced the latest installment of their Expert Opinion video news series. Crimson’s most recent program is based on research documenting the “Total Cost of Content” for medical device makers. According to U.S. manufacturers’ estimates, the total cost associated with creating, approving, updating, maintaining, translating, and formatting content in the key areas of Regulatory, Marketing, and Training amounts to approximately 1 percent of revenue, or $1 billion per year. Based on implementation of content and translation management strategies and technologies, Crimson estimates potential savings of up to 40 percent of this total ($400 million). The latest Expert Opinion segment is available for viewing here.